Achieve Life Sciences, Inc. Operating Income
Achieve Life Sciences, Inc. (ACHV) reported Operating Income of $8.29 million for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-08.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2012-11-08
- Achieve Life Sciences, Inc. operating income (loss) for the quarter ending 2012-09-30 was $8.29M, a 102.34% increase year-over-year.
- Achieve Life Sciences, Inc. operating income (loss) for the quarter ending 2012-06-30 was $5.94M, a 19.05% increase year-over-year.
- Achieve Life Sciences, Inc. operating income (loss) for the quarter ending 2012-03-31 was -$5.50M.
- Achieve Life Sciences, Inc. operating income (loss) for the quarter ending 2011-09-30 was $4.10M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed |
|---|---|---|---|---|---|---|
| 2012-09-30 | $8.29M 10-Q · filed 2012-11-08 | $14.23M derived: sum of 2 quarters · filed 2012-11-08 | $19.74M 10-Q · filed 2012-11-08 | |||
| 2012-06-30 | $5.94M 10-Q · filed 2012-08-02 | $11.45M 10-Q · filed 2012-08-02 | ||||
| 2012-03-31 | -$5.50M 10-Q · filed 2012-05-03 | |||||
| 2011-09-30 | $4.10M 10-Q · filed 2012-11-08 | -$4.10M 10-Q · filed 2011-11-03 | $9.09M derived: sum of 2 quarters · filed 2012-11-08 | $14.31M 10-Q · filed 2012-11-08 | -$14.31M 10-Q · filed 2011-11-03 | |
| 2011-06-30 | $4.99M 10-Q · filed 2012-08-02 | -$4.99M 10-Q · filed 2011-08-05 | $10.22M 10-Q · filed 2012-08-02 | -$10.22M 10-Q · filed 2011-08-05 | ||
| 2011-03-31 | -$5.22M 10-Q · filed 2012-05-03 | |||||
| 2010-09-30 | -$6.95M 10-Q · filed 2011-11-03 | -$9.80M derived: sum of 2 quarters · filed 2011-11-03 | -$12.83M 10-Q · filed 2011-11-03 | |||
| 2010-06-30 | -$2.85M 10-Q · filed 2011-08-05 | -$5.88M 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |